Transcat downgraded to Perform from Outperform at Oppenheimer

Oppenheimer downgraded Transcat (TRNS) to Perform from Outperform without a price target The company’s fiscal Q3 results fell short of expectations and Transcat reduced its fiscal 2025 organic service growth outlook, the analyst tells investors in a research note. The firm says the company has delivered three consecutive quarters of lower than expected organic service growth and its first quarter of organic service revenue decline. It steps to the sidelines pending more confidence in Transcat’s ability to deliver stable mid-to-long-term growth.